Data availability
The raw data associated with Fig. 1 are available from the corresponding author upon request.
References
Gerlach, D. et al. Methicillin-resistant Staphylococcus aureus alters cell wall glycosylation to evade immunity. Nature 563, 705–709 (2018).
Driguez, P. A. et al. Immunogenic compositions against S. aureus. WO patent WO/2017/064190 (2017).
Xia, G. et al. Glycosylation of wall teichoic acid in Staphylococcus aureus by TarM. J. Biol. Chem. 285, 13405–13415 (2010).
Brown, S. et al. Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids. Proc. Natl Acad. Sci. USA 109, 18909–18914 (2012).
Brown, E. J. et al. Anti-wall teichoic antibodies and conjugates. WO patent WO/2014/194247 (2015).
Kurokawa, K. et al. Glycoepitopes of staphylococcal wall teichoic acid govern complement-mediated opsonophagocytosis via human serum antibody and mannose-binding lectin. J. Biol. Chem. 288, 30956–30968 (2013).
Lee, J. H. et al. Surface glycopolymers are crucial for in vitro anti-wall teichoic acid IgG-mediated complement activation and opsonophagocytosis of Staphylococcus aureus. Infect. Immun. 83, 4247–4255 (2015).
Lehar, S. M. et al. Novel antibody-antibiotic conjugate eliminates intracellular S. aureus. Nature 527, 323–328 (2015).
Jung, D. J. et al. Specific serum Ig recognizing staphylococcal wall teichoic acid induces complement-mediated opsonophagocytosis against Staphylococcus aureus. J. Immunol. 189, 4951–4959 (2012).
Acknowledgements
This work was supported by a Vidi grant (91713303) from the Netherlands Organization of Scientific Research (NWO) to N.M.v.S. and R.v.D.
Author information
Authors and Affiliations
Contributions
R.v.D. and N.M.v.S. designed experiments and wrote the manuscript. R.v.D. and M.M.M. performed experiments and prepared figures. K.P.M.v.K., P.A. and C.J.C.d.H. provided technical assistance. S.A. and J.C. produced and provided essential reagents. K.P.M.v.K., J.A.G.v.S. and J.C. provided critical feedback.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information
This file contains Supplementary Methods, additional references and Supplementary Figure 1.
Rights and permissions
About this article
Cite this article
van Dalen, R., Molendijk, M.M., Ali, S. et al. Do not discard Staphylococcus aureus WTA as a vaccine antigen. Nature 572, E1–E2 (2019). https://doi.org/10.1038/s41586-019-1416-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41586-019-1416-8
- Springer Nature Limited
This article is cited by
-
A multi-enzyme machine polymerizes the Haemophilus influenzae type b capsule
Nature Chemical Biology (2023)
-
Staphylococcus epidermidis clones express Staphylococcus aureus-type wall teichoic acid to shift from a commensal to pathogen lifestyle
Nature Microbiology (2021)
-
A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A
Nature Communications (2020)
-
Reply to: Do not discard Staphylococcus aureus WTA as a vaccine antigen
Nature (2019)